Abstract:Amyloid plaque deposition is recognized as the primary pathological hallmark of Alzheimers disease(AD) that precedes other pathological events and cognitive symptoms. Plaque pathology represents itself with an immense polymorphic variety comprising plaques with different stages of amyloid fibrillization ranging from diffuse to fibrillar, mature plaques. The association of polymorphic Abeta plaque pathology with AD pathogenesis, clinical symptoms and disease progression remains unclear. Advanced chemical imaging tools, such as functional amyloid microscopy combined with MALDI mass spectrometry imaging (MSI), are now enhanced by deep learning algorithms. This integration allows for precise delineation of polymorphic plaque structures and detailed identification of their associated Abeta compositions. We here set out to make use of these tools to interrogate heterogenic plaque types and their associated biochemical architecture. Our findings reveal distinct Abeta signatures that differentiate diffuse plaques from fibrilized ones, with the latter showing substantially higher levels of Abeta x-40. Notably, within the fibrilized category, we identified a distinct subtype known as coarse-grain plaques. Both in sAD and fAD brain tissue, coarse grain plaques contained more Abeta x-40 and less Abeta x-42 compared with cored plaques. The coarse grain plaques in both sAD and fAD also showed higher levels of neuritic content including paired helical filaments (PHF-1)/phosphorylated phospho Tau-immunopositive neurites. Finally, the Abeta; peptide content in coarse grain plaques resembled that of vascular Abeta deposits (CAA) though with relatively higher levels of Abeta 1-42 and pyroglutamated Abeta x-40 and Abeta x-42 species in coarse grain plaques. This is the first of its kind study on spatial in situ biochemical characterization of different plaque morphotypes demonstrating the potential of the correlative imaging techniques used that further increase the understanding of heterogeneous AD pathology. Linking the biochemical characteristics of amyloid plaque polymorphisms with various AD etiologies and toxicity mechanisms is crucial. Understanding the connection between plaque structure and disease pathogenesis can enhance our insights. This knowledge is particularly valuable for developing and advancing novel, amyloid-targeting therapeutics.

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome

Three-dimensional Reconstruction and Analysis of Structure Characteristics on Senile Plaques of Alzheimer’s Disease

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

Delineating amyloid peptide signatures among heterogenous plaque population in Alzheimer’s Disease

Distinct Molecular Signatures of Amyloid-Beta and Tau in Alzheimer's Disease Associated with Down Syndrome

Not all plaques are created equal: Uncovering a unique molecular signature in Alzheimer's disease

High-resolution structures of amyloid-β and tau aggregates in individuals with Down syndrome

The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down's syndrome

Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain

Cryo-EM structures of amyloid-β and tau filaments in Down syndrome

Current hypotheses of Alzheimer disease neuropathology and dementia

Chemical imaging signatures delineate heterogeneous amyloid plaque populations across the Alzheimers disease spectrum

Increased BACE1 maturation contributes to the pathogenesis of Alzheimer's disease in Down syndrome.

Apolipoprotein Serum Amyloid A in Alzheimer's Disease.

Aβ Amyloid Scaffolds the Accumulation of Matrisome and Additional Proteins in Alzheimer's Disease

Senile Plaques in Alzheimer’s Disease Arise from Aβ and Cathepsin D-enriched Amyloidogenic Mixtures out of Intravascular Hemolysis and Charcot-Bouchard Aneurysm-Related Vascular Degeneration

Differential pattern of β-amyloid, amyloid precursor protein and apolipoprotein E expression in cortical senile plaques

Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection.

Aβ42 and Aβ40: similarities and differences.